» Articles » PMID: 34837985

Ocular Related Emergencies in Spain During the COVID-19 Pandemic, a Multicenter Study

Abstract

Purpose: To evaluate ophthalmological emergencies (OE) during the COVID-19 pandemic comparing them with the same period of the previous year.

Methods: Retrospective observational study of all OE visits in four tertiary hospitals in Spain comparing data from March 16th to April 30th, 2020 (COVID-19 period) and the same period of 2019 (pre-COVID-19 period). Severity of the conditions was assessed following Channa et al. publication. Data on demographics, diagnosis and treatments were collected from Electronic Medical Records.

Results: During lockdown, OE significantly declined by 75.18%, from 7,730 registered in the pre-COVID-19 period to 1,928 attended during the COVID-19 period (p < 0.001). In 2019, 23.86% of visits were classified as emergent, 59.50% as non-emergent, and 16.65% could not be determined. In 2020, the percentage of emergent visits increased up to 29.77%, non-emergent visits significantly decreased to 52.92% (p < 0.001), and 17.31% of the visits were classified as "could not determine". During the pandemic, people aged between 45 and 65 years old represented the largest attending group (37.89%), compared to 2019, where patients over 65 years were the majority (39.80%). In 2019, most frequent diagnosis was unspecified acute conjunctivitis (11.59%), followed by vitreous degeneration (6.47%), and punctate keratitis (5.86%). During the COVID-19 period, vitreous degeneration was the first cause for consultation (9.28%), followed by unspecified acute conjunctivitis (5.63%) and punctate keratitis (5.85%).

Conclusions: OE visits dropped significantly during the pandemic in Spain (75.18%), although more than half were classified as non-urgent conditions, indicating a lack of understanding of the really emergent ocular pathologies among population.

Citing Articles

Effects of the COVID-19 pandemic on the activity of clinical laboratories in Spain, evolution in the 2019-2021 period.

Lasierra Monclus A, Gonzalez A, Bernabeu Andreu F, Caballe Martin I, Buno Soto A, Ibarz M Adv Lab Med. 2023; 3(4):361-382.

PMID: 37363429 PMC: 10197302. DOI: 10.1515/almed-2022-0107.


Commentary: Post-pandemic lessons learnt regarding triage, mitigation, and management of emergency ocular conditions.

Sinha S, Nishant P, Kaur K, Gurnani B, Morya A Indian J Ophthalmol. 2023; 71(3):871-872.

PMID: 36872697 PMC: 10229911. DOI: 10.4103/ijo.IJO_2_23_2.

References
1.
Leal M, Beneyto P, Ibanez M, Garcia A, Fernandez M . [Have patients who go to the emergency department changed? Evolutive study for the years 1997 and 2005]. Arch Soc Esp Oftalmol. 2007; 82(3):159-65. DOI: 10.4321/s0365-66912007000300008. View

2.
Elfalah M, AlRyalat S, Toro M, Rejdak R, Zweifel S, Nazzal R . Delayed Intravitreal Anti-VEGF Therapy for Patients During the COVID-19 Lockdown: An Ethical Endeavor. Clin Ophthalmol. 2021; 15:661-669. PMC: 7898208. DOI: 10.2147/OPTH.S289068. View

3.
Dolar-Szczasny J, Toro M, Dworzanska A, Wojtowicz T, Korona-Glowniak I, Sawicki R . Ocular Involvement of SARS-CoV-2 in a Polish Cohort of COVID-19-Positive Patients. Int J Environ Res Public Health. 2021; 18(6). PMC: 8001647. DOI: 10.3390/ijerph18062916. View

4.
Tognetto D, Brezin A, Cummings A, Malyugin B, Kemer O, Prieto I . Rethinking Elective Cataract Surgery Diagnostics, Assessments, and Tools after the COVID-19 Pandemic Experience and Beyond: Insights from the EUROCOVCAT Group. Diagnostics (Basel). 2020; 10(12). PMC: 7761628. DOI: 10.3390/diagnostics10121035. View

5.
Lopez-Vazquez A, Lacorzana J . [AJOE: Our future. Are we facing the lost generations?]. Arch Soc Esp Oftalmol. 2021; 96(6):342-344. PMC: 7762620. DOI: 10.1016/j.oftal.2020.11.004. View